Christos Sotiriou Selected Research

Christos Sotiriou Research Topics

Disease

163	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2002
126	Neoplasms (Cancer) 03/2024 - 01/2002
17	Pathologic Complete Response 03/2024 - 04/2007
13	Neoplasm Metastasis (Metastasis) 08/2023 - 03/2007
12	Triple Negative Breast Neoplasms 12/2023 - 04/2010
4	Circulating Neoplastic Cells 07/2022 - 11/2007
4	Carcinoma (Carcinomatosis) 01/2021 - 02/2003
4	Residual Neoplasm 01/2019 - 07/2009
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2023 - 11/2017
2	Lung Neoplasms (Lung Cancer) 01/2021 - 11/2004
2	Turcot syndrome 01/2018 - 05/2016
2	Hypoxia (Hypoxemia) 10/2017 - 03/2008
2	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2017 - 08/2010
2	Carcinogenesis 02/2016 - 03/2011
2	Disease Progression 01/2016 - 07/2015
2	Ovarian Epithelial Carcinoma 09/2005 - 07/2002
2	Ovarian Neoplasms (Ovarian Cancer) 09/2004 - 07/2002
1	Pericarditis 12/2023
1	Microsatellite Instability 01/2023
1	Inflammation (Inflammations) 01/2023
1	Obesity 01/2023
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Stomach Neoplasms (Stomach Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

50	Estrogen ReceptorsIBA 01/2023 - 03/2003
32	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2010
29	Phenobarbital (Luminal)FDA Link 03/2024 - 09/2003
29	Trastuzumab (Herceptin)FDA Link 11/2023 - 11/2004
16	human ERBB2 proteinIBA 01/2021 - 01/2010
14	Messenger RNA (mRNA)IBA 01/2022 - 12/2006
13	RNA (Ribonucleic Acid)IBA 12/2023 - 12/2011
12	Tamoxifen FDA LinkGeneric 02/2016 - 12/2004
11	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 04/2007
11	Proteins (Proteins, Gene)FDA Link 11/2021 - 06/2005
9	Hormones (Hormone)IBA 11/2023 - 01/2011
9	Letrozole (Femara)FDA LinkGeneric 08/2022 - 01/2008
8	AnthracyclinesIBA 08/2017 - 01/2010
7	Lapatinib (GW572016)FDA Link 11/2023 - 04/2015
7	ErbB Receptors (EGF Receptor)IBA 09/2022 - 09/2014
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2007
7	Complementary DNA (cDNA)IBA 09/2005 - 01/2002
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 01/2008
5	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 10/2004
5	ParaffinIBA 12/2023 - 08/2010
5	Everolimus FDA Link 03/2022 - 01/2008
5	Epirubicin (Ellence)FDA LinkGeneric 01/2019 - 04/2011
4	durvalumabIBA 12/2023 - 08/2021
4	Formaldehyde (Formol)FDA Link 12/2023 - 10/2014
4	Circulating Tumor DNAIBA 09/2022 - 04/2018
4	taxaneIBA 01/2020 - 04/2007
4	Estrogens (Estrogen)FDA Link 02/2018 - 06/2009
4	MicroRNAs (MicroRNA)IBA 02/2016 - 03/2008
4	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2016 - 01/2013
4	Type II DNA Topoisomerases (Topoisomerase II)IBA 10/2013 - 10/2004
3	Carboplatin (JM8)FDA LinkGeneric 12/2023 - 03/2015
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 12/2004
3	Immune Checkpoint InhibitorsIBA 12/2021 - 06/2015
3	MucinsIBA 01/2021 - 01/2018
3	Docetaxel (Taxotere)FDA Link 01/2020 - 10/2004
3	Hematoxylin (Haematoxylon)IBA 12/2019 - 01/2017
3	Eosine Yellowish-(YS) (Eosin)IBA 12/2019 - 01/2017
3	Phosphotransferases (Kinase)IBA 04/2018 - 05/2014
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2016 - 11/2007
3	Peptide Hydrolases (Proteases)FDA Link 08/2010 - 03/2003
2	Adenosine (Adenocard)FDA LinkGeneric 12/2023 - 08/2021
2	Methotrexate (Mexate)FDA LinkGeneric 12/2023 - 01/2019
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2023 - 11/2018
2	Monoclonal AntibodiesIBA 08/2023 - 01/2016
2	beta-2 Adrenergic ReceptorsIBA 07/2023 - 01/2020
2	Complement System Proteins (Complement)IBA 07/2022 - 12/2021
2	B7-H1 AntigenIBA 12/2021 - 01/2019
2	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 06/2009
2	Aromatase InhibitorsIBA 01/2021 - 06/2009
2	Taxoids (Taxanes)IBA 01/2020 - 04/2010
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 06/2017
2	Interferon Type IIBA 01/2019 - 10/2015
2	EnzymesIBA 01/2018 - 02/2016
2	Fluorouracil (Carac)FDA LinkGeneric 02/2017 - 07/2015
2	Small Interfering RNA (siRNA)IBA 10/2015 - 02/2010
2	InterferonsIBA 01/2013 - 07/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2012 - 06/2009
2	Keratin-19 (Keratin 19)IBA 12/2007 - 11/2007
2	Bortezomib (Velcade)FDA Link 12/2006 - 06/2004
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023
1	LigandsIBA 12/2023
1	Netrin-1IBA 08/2023
1	CalciumIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	COUP Transcription Factor IIIBA 11/2021
1	heparanaseIBA 05/2021
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2021
1	6-methyladenineIBA 01/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2021
1	N-methyladenosineIBA 01/2021
1	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 01/2021

Therapy/Procedure

60	Therapeutics 12/2023 - 08/2002
36	Drug Therapy (Chemotherapy) 12/2023 - 01/2002
23	Neoadjuvant Therapy 03/2024 - 07/2009
11	Adjuvant Chemotherapy 08/2021 - 11/2007
8	Immunotherapy 11/2023 - 01/2013
2	Radiotherapy 12/2023 - 08/2021